Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Zero2IPO Ventures

Founders Gavin Ni

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 86
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 73
Rounds per year 4.78
Lead investments 11
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.15
Exits 11
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • E-Commerce
  • Internet
  • Education
  • Health Care
  • Mobile
Summary

The company was established in Asia in China. The main department of described VC is located in the Beijing.

The current fund was established by Gavin Ni. The overall number of key employees were 1.

The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2017. The fund is generally included in 2-6 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Zero2IPO Ventures works on 16 percentage points less the average amount of lead investments.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Zero2IPO Ventures, startups are often financed by IDG Capital, Sequoia Capital China, BlueRun Ventures. The meaningful sponsors for the fund in investment in the same round are IDG Capital, Matrix Partners China, Kleiner Perkins. In the next rounds fund is usually obtained by GGV Capital, Sequoia Capital China, Sequoia Capital.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Internet, Shopping. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Meilishuo, Bona Film Group, Yesmywine

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Zero2IPO Ventures:
Typical Co-investors
Zero2IPO Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Zero2IPO Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3K.com -
Atlanta Equity Atlanta, Georgia, United States
Bozhong.com China, Guangdong, Guangzhou
Business Solutions Horsham, Pennsylvania, United States
CATCHER TECHNOLO RG Taipei, Taiwan
Cattles Invoice Finance Abingdon, Oxfordshire, United Kingdom
CIH Investment Capital Limited Central, Central Region, Singapore
Connector Media -
Huijunfeng Zichan China, Shanghai
Newfire Global Partners Cambridge, Massachusetts, United States
RIC Capital Management China, Shanghai
Scientipole Ile-de-France Capital France, Ile-de-France, Orsay
Shanghai Lindian Wangluo Keji Youxian Gongsi China, Shanghai
Shenzhen Press Group China, Guangdong, Shenzhen
Telstra Ventures California, San Francisco, United States
Tuhua Fund Auckland, Auckland, New Zealand
UOB Investment Beijing, China, Haidian
Wind Capital -
Ying Feng Investment Create Value China, Fujian, Xiamen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

HanchorBio

$20M25 Aug 2022 Taipei, Taiwan

AlpsenTek

Artificial Intelligence
Semiconductor
Sensor
$29M06 Jun 2022 Zurich, Zurich, Switzerland

Reistone Biopharma

Biotechnology
Pharmaceutical
$100M09 May 2022 Pudong, Shandong, China

Pleryon Therapeutics

Biopharma
Pharmaceutical
$15M01 Apr 2022 Shenzhen, Guangdong, China

TsIntergy Technology

Artificial Intelligence
Energy
Internet
$15M04 Mar 2022 Beijing, Beijing, China

Scent Library

$10M16 Sep 2021 Dongcheng, Shaanxi, China

X-ABT

Biotechnology
Health Care
Medical
$7M24 Mar 2020 Changping District, Beijing, China

Happyeasygo Group

Tourism
Travel
$45M12 Dec 2019 Gurugram, Haryana, India

Communities
Food and Beverage
$5M25 Oct 2019 Guangxi

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Zero2IPO Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 86
Average round size 11M
Rounds per year 4.78
Peak activity year 2018
Lead investments 11
Follow on index 0.15
Exits 11
Group Appearance index 0.86

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

HanchorBio

$20M25 Aug 2022 Taipei, Taiwan

AlpsenTek

Artificial Intelligence
Semiconductor
Sensor
$29M06 Jun 2022 Zurich, Zurich, Switzerland

Reistone Biopharma

Biotechnology
Pharmaceutical
$100M09 May 2022 Pudong, Shandong, China

Pleryon Therapeutics

Biopharma
Pharmaceutical
$15M01 Apr 2022 Shenzhen, Guangdong, China

TsIntergy Technology

Artificial Intelligence
Energy
Internet
$15M04 Mar 2022 Beijing, Beijing, China

Scent Library

$10M16 Sep 2021 Dongcheng, Shaanxi, China

X-ABT

Biotechnology
Health Care
Medical
$7M24 Mar 2020 Changping District, Beijing, China

Happyeasygo Group

Tourism
Travel
$45M12 Dec 2019 Gurugram, Haryana, India

Communities
Food and Beverage
$5M25 Oct 2019 Guangxi
Crunchbase icon

Content report

The following text will be sent to our editors: